Literature DB >> 15356145

Phosphorylation of Grb2-associated binder 2 on serine 623 by ERK MAPK regulates its association with the phosphatase SHP-2 and decreases STAT5 activation.

Mary Arnaud1, Catherine Crouin, Catherine Deon, Denis Loyaux, Jacques Bertoglio.   

Abstract

IL-2 stimulation of T lymphocytes induces the tyrosine phosphorylation and adaptor function of the insulin receptor substrate/Grb2-associated binder (Gab) family member, Gab2. In addition, Gab2 undergoes a marked decrease in its mobility in SDS-PAGE, characteristic of migration shifts induced by serine/threonine phosphorylations in many proteins. This migration shift was strongly diminished by treating cells with the MEK inhibitor U0126, indicating a possible role for ERK in Gab2 phosphorylation. Indeed, ERK phosphorylated Gab2 on a consensus phosphorylation site at serine 623, a residue located between tyrosine 614 and tyrosine 643 that are responsible for Gab2/Src homology 2 domain-containing tyrosine phosphatase (SHP)-2 interaction. We report that pretreatment of Kit 225 cells with U0126 increased Gab2/SHP-2 association and tyrosine phosphorylation of SHP-2 in response to IL-2, suggesting that ERK phosphorylation of serine 623 regulates the interaction between Gab2 and SHP-2, and consequently the activity of SHP-2. This hypothesis was confirmed by biochemical analysis of cells expressing Gab2 WT, Gab2 serine 623A or Gab2 tyrosine 614F, a mutant that cannot interact with SHP-2 in response to IL-2. Activation of the ERK pathway was indeed blocked by Gab2 tyrosine 614F and slightly increased by Gab2 serine 623A. In contrast, STAT5 activation was strongly enhanced by Gab2 tyrosine 614F, slightly reduced by Gab2 WT and strongly inhibited by Gab2 serine 623A. Analysis of the rate of proliferation of cells expressing these mutants of Gab2 demonstrated that tyrosine 614F mutation enhanced proliferation whereas serine 623A diminished it. These results demonstrate that ERK-mediated phosphorylation of Gab2 serine 623 is involved in fine tuning the proliferative response of T lymphocytes to IL-2. Copyright 2004 The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15356145     DOI: 10.4049/jimmunol.173.6.3962

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

1.  The IKK-neutralizing compound Bay11 kills supereffector CD8 T cells by altering caspase-dependent activation-induced cell death.

Authors:  Seung-Joo Lee; Meixiao Long; Adam J Adler; Robert S Mittler; Anthony T Vella
Journal:  J Leukoc Biol       Date:  2008-10-15       Impact factor: 4.962

2.  CUX1 and E2F1 regulate coordinated expression of the mitotic complex genes Ect2, MgcRacGAP, and MKLP1 in S phase.

Authors:  Laetitia Seguin; Caroline Liot; Rym Mzali; Ryoko Harada; Aurelie Siret; Alain Nepveu; Jacques Bertoglio
Journal:  Mol Cell Biol       Date:  2008-11-17       Impact factor: 4.272

3.  Suberosin inhibits proliferation of human peripheral blood mononuclear cells through the modulation of the transcription factors NF-AT and NF-kappaB.

Authors:  Y-C Chen; W-J Tsai; M-H Wu; L-C Lin; Y-C Kuo
Journal:  Br J Pharmacol       Date:  2006-12-18       Impact factor: 8.739

4.  Gab2 phosphorylation by RSK inhibits Shp2 recruitment and cell motility.

Authors:  Xiaocui Zhang; Genevieve Lavoie; Loic Fort; Edward L Huttlin; Joseph Tcherkezian; Jacob A Galan; Haihua Gu; Steven P Gygi; Sebastien Carreno; Philippe P Roux
Journal:  Mol Cell Biol       Date:  2013-02-11       Impact factor: 4.272

5.  Scaffolding protein Grb2-associated binder 1 sustains epidermal growth factor-induced mitogenic and survival signaling by multiple positive feedback loops.

Authors:  Anatoly Kiyatkin; Edita Aksamitiene; Nick I Markevich; Nikolay M Borisov; Jan B Hoek; Boris N Kholodenko
Journal:  J Biol Chem       Date:  2006-05-09       Impact factor: 5.157

6.  Predisposing germline mutations in high hyperdiploid acute lymphoblastic leukemia in children.

Authors:  Adam J de Smith; Geneviève Lavoie; Kyle M Walsh; Sumeet Aujla; Erica Evans; Helen M Hansen; Ivan Smirnov; Alice Y Kang; Martin Zenker; John J Ceremsak; Elliot Stieglitz; Ivo S Muskens; William Roberts; Roberta McKean-Cowdin; Catherine Metayer; Philippe P Roux; Joseph L Wiemels
Journal:  Genes Chromosomes Cancer       Date:  2019-05-27       Impact factor: 5.006

7.  Phosphorylation-dependent binding of 14-3-3 terminates signalling by the Gab2 docking protein.

Authors:  Tilman Brummer; Mark Larance; Maria Teresa Herrera Abreu; Ruth J Lyons; Paul Timpson; Christoph H Emmerich; Emmy D G Fleuren; Gillian M Lehrbach; Daniel Schramek; Michael Guilhaus; David E James; Roger J Daly
Journal:  EMBO J       Date:  2008-09-03       Impact factor: 11.598

8.  Human CD4(+) effector T lymphocytes generated upon TCR engagement with self-peptides respond defectively to IL-7 in their transition to memory cells.

Authors:  Gabriela González-Pérez; Norma C Segovia; Amaranta Rivas-Carvalho; Diana P Reyes; Honorio Torres-Aguilar; Sergio R Aguilar-Ruiz; Claudine Irles; Gloria Soldevila; Carmen Sánchez-Torres
Journal:  Cell Mol Immunol       Date:  2013-03-04       Impact factor: 11.530

9.  Function, regulation and pathological roles of the Gab/DOS docking proteins.

Authors:  Franziska U Wöhrle; Roger J Daly; Tilman Brummer
Journal:  Cell Commun Signal       Date:  2009-09-08       Impact factor: 5.712

10.  Gab2 promotes hematopoietic stem cell maintenance and self-renewal synergistically with STAT5.

Authors:  Geqiang Li; Zhengqi Wang; Kristy L Miskimen; Yi Zhang; William Tse; Kevin D Bunting
Journal:  PLoS One       Date:  2010-02-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.